CCDI Scientific Director at NCI
When Dr. Gregory Reaman (he/him) was a child, nobody talked about what happened to a neighborhood boy who became sick, went to the hospital, and never came home. It was later that Greg found out that his neighbor had passed away from leukemia. This early experience and other formative moments throughout medical school and residency inspired Greg to pursue a career in pediatrics—especially pediatric oncology—and invest in translational research to improve outcomes for children with cancer. He’s since held leadership positions in childhood cancer research, including founding chair of the Children’s Oncology Group, associate director for pediatric oncology at the US Food and Drug Administration, and now, CCDI scientific director.
“The power of childhood cancer data speaks for itself,” he said, “and being able to aggregate, share, and broadly use these data outside of individual projects has enormous opportunities.” His hope for CCDI is that it models what’s achievable in cancer research, even outside of the pediatric population.